X
04Mar

HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums

In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By: Foley & Lardner LLP
Source Url: https://www.jdsupra.com/legalnews/hhs-gives-new-guidance-on-drug-21788/

Related

An Equitable Exception To the Four Corners Rule: The Eleventh Circuit Looks Beyond Operative Complaint To Find No Duty To Defend

Under Florida law, similar to that of other states, an insurer’s duty to defend is generally determ...

Read More >

Why Transgender Bias Isn't "Sex Discrimination"

According to the DOJ. I finally had a chance to read the brief of the Solicitor General in the R.G....

Read More >

ERISA Preemption Makes A Return To The Supreme Court

The U.S. Supreme Court recently agreed to hear Rutledge v. Pharmaceutical Care Management Associatio...

Read More >

SECURE Act Makes Big Changes to Retirement Plans

Employers, plan sponsors, and plan administrators ring in the New Year with new recordkeeping and ad...

Read More >

Chewing Through Baskets: The “Chewy Phantom Guarantee” and a Cautionary Tale of the Release of a Valuable Guarantee and Collateral Package

American pet owners are probably all familiar with Chewy, an e-commerce pet food and products suppli...

Read More >

Employers Have New Ways to Offer Health Reimbursement Arrangements

The Departments of Labor, Health and Human Services and Treasury recently issued joint final regulat...

Read More >